GAL3 Protein Expression is Related to Clinical Features of Prolactin-Secreting Pituitary Microadenoma and Predicts its Recurrence after Surgical Treatment | Zendy

Dongwei Dai | Zendy; Yanan Li | Zendy; Qiong Lu | Zendy; Longyang Yu | Zendy; Weijie Min | Zendy; Laixing Wang | Zendy; Yiqun Cao | Zendy; Zhijian Yue | Zendy

Open Access

GAL3 Protein Expression is Related to Clinical Features of Prolactin-Secreting Pituitary Microadenoma and Predicts its Recurrence after Surgical Treatment

Author(s) -

Dongwei Dai,

Yanan Li,

Qiong Lu,

Longyang Yu,

Weijie Min,

Laixing Wang,

Yiqun Cao,

Zhijian Yue

Publication year - 2014

Publication title -

cellular physiology and biochemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.486

H-Index - 87

eISSN - 1421-9778

pISSN - 1015-8987

DOI - 10.1159/000358673

Subject(s) - prolactin , transfection , in vivo , small interfering rna , pituitary tumors , cancer research , apoptosis , carcinogenesis , in vitro , immunohistochemistry , cell growth , cell culture , medicine , biology , endocrinology , cancer , hormone , biochemistry , microbiology and biotechnology , genetics

Previous in vitro study showed that Galectin-3 (Gal-3) protein plays an important role in pituitary tumorigenesis, however, the association of Gal-3 expression with the clinical feature and prognosis of pituitary tumor in a clinical setting remains unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research